AJANTPHARM.NSE logo

AJANTPHARM.NSE
Ajanta Pharma Ltd.

107
Loading...
Loading...
News
all
press releases
Ajanta Pharma, Sun Pharma poised to tap GLP-1 opportunity amid market shift: Siddhartha Khemka
India's metabolic therapy market is transforming post-semaglutide patent expiry, shifting to a competitive, volume-driven model. With significant price drops and increased launches, demand is surging among millions needing obesity management. Broader specialist adoption and a growing prescriber base are fueling this expansion, promising substantial market growth.
cityfalcon.com·8d ago
News Placeholder
More News
News Placeholder
India’s Cheap Ozempic Moment Is Here: Ozempic Prices Set to Drop to ₹3,000 as Semaglutide Goes Off-Patent in India
… in the highly successful weight-loss drugs called “Ozempic” and “Wegovy” developed … such as Mankind Pharma Ltd., Ajanta Pharma Ltd., Sun Pharmaceutical Industries Ltd. and … nearly 20% of all generic drugs available globally. The most significant impact …
cityfalcon.com·13d ago
News Placeholder
Raja Venkatraman, MarketSmith India recommends five stocks for 16 March
On March 13, Indian stock indices Sensex and Nifty 50 faced continued selling pressure due to rising crude oil prices and global economic concerns. GIFT Nifty today suggests a mildly positive start, with several stocks recommended for buying, including Ajanta Pharma and Power Grid Corporation.
cityfalcon.com·20d ago
News Placeholder
Everstone to sell stake in Restaurant Brands Asia – report
The family office of the founders of Ajanta Pharma in India may inject up to Rs8bn ($88m) into RBA.
cityfalcon.com·3mo ago
News Placeholder
Everstone to sell entire stake in India's Burger King operator Restaurant Brands Asia, sources say
Private equity firm Everstone is set to exit Restaurant Brands Asia, the franchisee for Burger King in India and Indonesia. The firm will sell its entire 11.26% stake. The Ajanta Pharma family office is poised to become the new strategic investor. This move could see the family office injecting significant funds and potentially acquiring a majority stake in the company.
cityfalcon.com·3mo ago
<
...
1
>

Latest AJANTPHARM.NSE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.